Elevated C-Reactive Protein Management

Initial Assessment and Diagnostic Approach

CRP values >10 mg/L should prompt a thorough clinical evaluation for potential sources of infection or inflammation, as recommended by the European medical community 1, 2
Clinical assessment alone is unreliable for determining severity of inflammatory conditions; objective criteria including CRP should be used, according to the European Society of Gastroenterology 3
Assess for fever, tachycardia, and other vital sign abnormalities, and evaluate for cardinal symptoms of infection or inflammation based on organ systems, as suggested by the European Heart Society 4, 3

Blood cultures should be taken if infection is suspected, as recommended by the European Heart Society 4
Liver function tests should be performed to rule out hepatic inflammation, according to the Brain, Behavior, and Immunity guidelines 1
Consider disease-specific biomarkers based on clinical suspicion, as suggested by the Gastroenterology society 5, 6

In patients with inflammatory bowel disease, use CRP in combination with symptoms to guide treatment decisions, as recommended by the Gastroenterology society 7, 5, 6
CRP >5 mg/L in symptomatic patients suggests active inflammation requiring treatment adjustment, according to the Gastroenterology guidelines 5, 6
Categorize CRP values for cardiovascular risk: Low risk (<1.0 mg/L), Average risk (1.0-3.0 mg/L), High risk (>3.0 mg/L), as suggested by the American College of Cardiology 2
For stable assessment, average two measurements taken 2 weeks apart, as recommended by the American Heart Association 2

CRP values >10 mg/L are not always indicative of acute infection/injury; consider demographic, behavioral, and technical factors, as noted by the Brain, Behavior, and Immunity society 1, 8
CRP normalizes more quickly than ESR during resolution of inflammation, according to the European medical community 2

Document any recent trauma, surgery, or known inflammatory conditions in patients with elevated CRP, as these factors can contribute to elevated CRP levels 9
Check liver function tests to exclude hepatic inflammation or fatty liver disease as a cause of elevated CRP, as recommended by the American Gastroenterological Association 9

For patients with inflammatory bowel disease, a CRP level >5 mg/L in symptomatic patients suggests active endoscopic inflammation requiring treatment adjustment, according to the American Gastroenterological Association 10
The sensitivity for detecting moderate-to-severe endoscopic activity in inflammatory bowel disease is 67% with specificity of 77% when using CRP in combination with symptoms, as reported by the American Gastroenterological Association 11, 10

Elevated CRP in patients with acute coronary syndrome indicates increased adverse outcome risk even without myocardial necrosis, as stated by the American Heart Association 12